Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: Clinical practice guidelines (CPGs) provide evidence-based recommendations for patient care; however, integrating them into artificial intelligence (AI) remains challenging. Previous approaches, such as rule-based systems or black-box AI models, face significant limitations, including poor interpretability, inconsistent adherence to guidelines, and narrow domain applicability. To addres...
Background Gastric intestinal metaplasia (GIM) is a well-established precancerous lesion and key biomarker for assessing the risk of gastric cancer. Histological classification into complete and incomplete types, along with the Operative Link on Gastric Intestinal Metaplasia (OLGIM), provides valuable prognostic information, with stage III-IV strongly associated with cancer development. Therefore,...
Breast cancer diagnosis from histopathology images remains challenging due to two intertwined factors: severe class imbalance, where malignant cases r...
Breast cancer ranks as the second leading cause of death in women. Early identification of breast cancer can significantly reduce women's mortality ra...
AIM: The clinical evaluation of patients with oral potentially malignant disorders is primarily based on physical examination and observable clinical ...
BACKGROUND: Developments in artificial neural networks (ANNs) offer significant promise for cancer screening and risk prediction, with the potential t...
BACKGROUND AND PURPOSE: Cardiovascular disease (CVD) is the leading cause of death globally [1] as well as the leading cause of death among cancer sur...
The treatment paradigm for lymphoma, a highly heterogeneous group of hematologic malignancies, has been revolutionized by the development of therapies...
Cancer immunotherapy, which leverages the immune system to combat tumor cells, has made significant advancements in oncology treatment in recent years...
The integration of artificial intelligence into pathology is transforming the assessment of histological and immunohistochemical (IHC) slides, offerin...
Discovery of phenotype-associated subpopulations is critical for targeted therapies and prognostic biomarker discovery, which requires multi-scale gen...
OBJECTIVE: Insidiousness is a hallmark of metachronous liver metastasis. Owing to the absence of a comprehensive machine-learning model integrating sy...
BACKGROUND: Superficial esophageal squamous cell carcinoma (ESCC) is increasingly detected due to enhanced endoscopic surveillance, yet accurately pre...
BACKGROUND: Colorectal cancer (CRC) represents the third most prevalent malignancy worldwide and accounts for the second-highest cancer-related mortal...
PURPOSE: Despite Phosphoenolpyruvate carboxykinase 2 (PCK2) has attracted growing attention as a potential biomarker in cancer research, its role in m...
Isoform-selective inhibition of class I phosphoinositide 3-kinases (PI3Ks) remains a major challenge in oncology and immune-mediated diseases, where d...
Advances in immunotherapy, particularly with immune checkpoint inhibitors, have improved clinical outcomes in various cancer subtypes; however, resist...
BACKGROUND: Precise delineation of non-contrast-enhancing tumor (nCET) in glioblastoma (GB) is critical for maximal safe resection, yet routine imagin...
Colorectal cancer (CRC) is one of the most prevalent and deadly cancers worldwide, with late-stage diagnosis often associated with poor prognosis. The...